steroid-induced adrenal insufficiency is time
dependent and the adverse effects are generally
reversible with lower dosage or discontinuation of
treatment. Abrupt cessation of the drugs may
precipitate adrenocortical insufficiency, therefore the
drugs must be gradually discontinued. (Stratakis
CA,2018;Lodish MB et al., 2018). The physiologic
dose of steroids should be given for about 6-9 months
because the recovery period of HPA axis suppression
is 3.49 ± 2.92 months.(
Tempark T et al., 2010). Our
patient was tapered down slowly over the past 3
months and was planned to have her morning cortisol
level check again in May 2019, 6 months after the
initial test.
Depends on the severity, treatments available for
childhood psoriasis are emollients, salicylic acid,
calcipotriol, coal tar, topical steroids, phototherapy,
retinoids, and cyclosporine (Rahmayunita G et al.,
2008). Topical steroids are not indicated in severe
psoriasis due to the possible side effects of excessive
usage. Whereas first line treatment for erythrodermic
or pustular psoriasis is acitretin, followed by
cyclosporine, phototherapy, methotrexate, anti-TNF
agents, and systemic steroids.(Bronckers et al., 2015;
Gudjonsson JE et al, 2012). Acute GPP has proven to
be, like many psoriasis variants, a difficult disease to
treat. (Hyde K et al., 2016). Severe and extensive
disease is likely to most effectively be treated with
infliximab (TNF-α inhibitor) or cyclosporine, given
the quicker onset of action with these drugs. (Hyde K
et al., 2016). Our patient was prescribed cyclosporine
with initial dose of 100 mg daily. Cyclosporine is an
calcineurin inhibitor which inhibits the T-cell
activation mediated by antigen. (Gudjonsson JE et al,
2012) It has a rapid onset of action of 2-4 weeks and
notable side effects are nephrotoxicity, hypertension,
nausea, and diarrhea.(Bronckers et al., 2015;
Gudjonsson JE et al, 2012) To date, the efficacy of
cyclosporine in pediatric psoriasis is limited. (Hyde K
et al., 2016).
Children may require higher dosage than
recommended in adults because of greater body
surface area to weight ratio. Therefore, the lowest
possible dose and shortest treatment period should be
used.(Bronckers et al., 2015;Al Aboud DM et al et
al., 2019;Hyde K et al., 2016).
Ideally high-potency topical steroids should be
obtained only with prescription in order to prevent
misuse of topical steroids.(Sahana PK et al., 2015)
Patients and especially parents should be informed
about the appropriate usage and the possible side
effects of the drug.Children are more susceptible to
side effects, thus parents should clearly understand
how to use topical steroid wisely. One of the side
effects of steroids is immunosuppression which may
increase the risk of opportunistic and bacterial
infections. Semiz et al reported a fatal case of
disseminated cytomegalovirus infection in a
Cushing’s syndrome patient due to topical steroid use
in the diaper area.(Semiz S et al., 2008). Therefore,
topical steroids should be used wisely especially in
children.
4 CONCLUSION
Adverse effects of steroid-induced adrenal
insufficiency is generally reversible and the recovery
is time dependent thus the cessation of exogenous
steroid should be gradual. During the gradual
discontinued of exogenous steroids, systemic agents
for psoriasis ie.acitretin orcyclosporine should be
initiated. Parents should be noted that misuse of
topical and oral corticosteroids could be harmful for
children and severe immunosuppression state could
end fatally.
REFERENCES
Al Aboud DM, Kumar S. Pustular psoriasis. 2019. In:
StatPearls [Internet]. Treasure Island (FL).
Bronckers IMGJ, Paller AS, Geel MJ, Kerkhof PCM,
Seyger MMB. 2015. Psoriasis in children and
adolescents: diagnosis, management and comorbidities.
Pediatr Drugs.;17(5):373-384.
Gudjonsson JE, Elder JT. Psoriasis. In: Goldsmith L, Katz
S, Gilchrest B, Paller A, Leffell D, Wolff K, eds 2012..
Fitzpatricks’s Dermatology in General Medicine.
Eight. McGraw-Hill;:197-231
Hyde K, Kivelevitch D, Mansouri B. 2016. Pustular
psoriasis: pathophysiology and current treatment
perspectives. Psoriasis Targets Ther.;6:131-144.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. 2006.
Adverse effects of topical glucocorticosteroids. J Am
Acad Dermatol.:1-15.
Liu D, Ahmet A, Ward L, et al. 2013. A practical guide to
the monitoring and management of the complications
of systemic corticosteroid therapy. Allergy Asthma Clin
Immunol.;9(1):30.
Lodish MB, Keil MF, Stratakis CA. 2018. Cushing’s
syndrome in pediatrics: an update. Endocrinol Metab
Clin N Am.;47:451-462.
Meena S, Gupta LK, Khare AK, et al. 2017.Topical
corticosteroids abuse: a clinical study of cutaneous
adverse effects. Indian J Dermatol.;62(6):675.
Rahmayunita G, Pulungan AB, Wiryadi BE, Wisesa TW,
Sugito TL. 2008. Cushing’s syndrome induced by
misuse of topical corticosteroids in a child with
psoriasis vulgaris. Med J Indones.;17(4):281-286.
Raff H, Sharma ST, Nieman LK. 2014.Physiological basis
for the etiology, diagnosis, and treatment of adrenal